Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

324 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The rectum: a window to irritable bowel syndrome?
Coremans G, Azpiroz F, Collins S, Dapoigny M, Müller-Lissner SA, Pace F, Smout A, Stockbrügger RW, Whorwell PJ. Coremans G, et al. Among authors: pace f. Digestion. 2002;65(4):238-49. doi: 10.1159/000063823. Digestion. 2002. PMID: 12239466 Review.
Motility in irritable-bowel syndrome.
Müller-Lissner S, Coremans G, Dapoigny M, Pace F, Smout A, Stockbrügger RW, Tougas G, Whorwell PJ, Wienbeck M. Müller-Lissner S, et al. Among authors: pace f. Digestion. 1997;58(2):196-202. doi: 10.1159/000201444. Digestion. 1997. PMID: 9144311 No abstract available.
Epidemiological aspects of irritable bowel syndrome in Europe and North America.
Müller-Lissner SA, Bollani S, Brummer RJ, Coremans G, Dapoigny M, Marshall JK, Muris JW, Oberndorff-Klein Wolthuis A, Pace F, Rodrigo L, Stockbrügger R, Vatn MH. Müller-Lissner SA, et al. Among authors: pace f. Digestion. 2001;64(3):200-4. doi: 10.1159/000048862. Digestion. 2001. PMID: 11786669
Therapy of irritable bowel syndrome--an overview.
Pace F, Coremans G, Dapoigny M, Müller-Lissner SA, Smout A, Stockbruegger RW, Whorwell PJ. Pace F, et al. Digestion. 1995;56(5):433-42. doi: 10.1159/000201272. Digestion. 1995. PMID: 8549889 No abstract available.
Randomised clinical trial: mucosal protection combined with acid suppression in the treatment of non-erosive reflux disease - efficacy of Esoxx, a hyaluronic acid-chondroitin sulphate based bioadhesive formulation.
Savarino V, Pace F, Scarpignato C; Esoxx Study Group. Savarino V, et al. Among authors: pace f. Aliment Pharmacol Ther. 2017 Mar;45(5):631-642. doi: 10.1111/apt.13914. Epub 2017 Jan 24. Aliment Pharmacol Ther. 2017. PMID: 28116754 Free PMC article. Clinical Trial.
324 results